ABBOTT LABORATORIES Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
ABBOTT LABORATORIES (ABT) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of -$3.07 billion for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-27.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2015-02-27
- ABBOTT LABORATORIES other comprehensive income (loss), before reclassifications, net of tax for fiscal 2014 was -$3.07B, a 677.40% decline from fiscal 2013.
- ABBOTT LABORATORIES other comprehensive income (loss), before reclassifications, net of tax for fiscal 2013 was $531.00M.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|
| 2014-12-31 | -$3.07B 10-K · filed 2015-02-27 |
| 2013-12-31 | $531.00M 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |